_{<strike id="svp1x"><listing id="svp1x"></listing></strike>}

EN 

中文
EN

About Us
About Us
Overview

History

Honor

Contact Us
Continuous innovation for better life

Founded in 1995, Jiangsu Hansoh Pharmaceutical Group Co., Ltd. is an innovation-driven pharmaceutical company integrating the R&D, manufacturing, and sales of drugs. As a principal subsidiary of Hansoh Pharma (03692.HK), the Company is committed to improving human health through continuous innovation, particularly in the treatment of major diseases including the areas of oncology, infections, the central nervous system, metabolic disorders, and autoimmune disease.
Innovation
Innovation
Achievements

Therapy Areas

R&D Platforms

R&D Capability
Continuous innovation for better life

Hansoh Pharma, a leading innovation-driven pharmaceutical company in the PRC, is committed to improving human health through unremitting innovation, focusing mainly on such areas as anti-tumor, anti-infectives, CNS diseases, metabolic diseases, autoimmune diseases.
Products
Products
Key Products
Continuous innovation for better life

After more than 20 years of continuous investment in R&D, Jiangsu Hansoh Pharma has marketed 7 innovative drugs and has over 30 innovative drug programs in different clinical stages with over 50 clinical trials in progress, forming a rich pipeline.
Manufacturing
Manufacturing
Lean Manufacturing

Quality Management
Continuous innovation for better life

Hansoh Pharma has always maintained dynamic consistency with global advanced access levels by continuously designing and building production facilities and production lines in accordance with international advanced standards and by using advanced production equipment.
Marketing Service
Marketing Service
Market Coverage

Hengte Pharmacy
Continuous innovation for better life

Under the new normal in the pharmaceutical industry, Jiangsu Hansoh Pharma endeavors to be proactive in the implementation of national policies and the innovation of business structure.
News
News
Press Releases

Media Center
Hansoh Pharma updates

Find the latest and most complete information about Hansoh Pharma!
Social Responsibility
Social Responsibility
Responsible Governance

Green Development

Public Charity
Responsibility integrity diligence innovation

Jiangsu Hansoh Pharma always adheres to the core values of responsibility, integrity, diligence, and innovation, serving human health with scientific and technological innovation, and assuming corporate social responsibility with accountable behavior in conducting business.
Careers
Careers
Work with Us

Join Us
Work with us

We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!

中文

About Us 
- Back
- Overview
- History
- Honor
- Contact Us
Innovation 
- Back
- Achievements
- Therapy Areas
- R&D Platforms
- R&D Capability
Products 
- Back
- Key Products
Manufacturing 
- Back
- Lean Manufacturing
- Quality Management
Marketing Service 
- Back
- Market Coverage
- Hengte Pharmacy
News 
- Back
- Press Releases
- Media Center
Social Responsibility 
- Back
- Responsible Governance
- Green Development
- Public Charity
Careers 
- Back
- Work with Us
- Join Us



R&D Capability

Remarkable R&D capabilities with over 20 years of R&D experience, Jiangsu Hansoh Pharma has several national-level R&D destinations, including the National Enterprise Technology Centers, Post-doctoral Research Station, and Key National Laboratory. The Company is highly efficient to discover innovative drugs, with R&D structure that covers areas such as peptides, biologics, small molecules, ADC drugs, and siRNAs.

7

launched innovative drugs
40

innovative drug candidates
60 ⁺

clinical trials of innovative drug candidates being investigated
60 ⁺

national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
2

second prizes of National Science and Technology Progress Award
2

China Patent Gold Award
600 ⁺

authorized invention patents at home and abroad
200 ⁺

contributions to national standards